edaravone has been researched along with Myocarditis in 4 studies
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we tested the hypothesis that MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one; edaravone), a novel free radical scavenger, protects against acute experimental autoimmune myocarditis (EAM) in rats by the radical scavenging action associated with the suppression of cytotoxic myocardial injury." | 7.73 | MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats. ( Hattori, M; Kishimoto, C; Nimata, M; Okabe, TA; Shioji, K; Yuan, Z, 2005) |
| "In this study, we tested the hypothesis that MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one; edaravone), a novel free radical scavenger, protects against acute experimental autoimmune myocarditis (EAM) in rats by the radical scavenging action associated with the suppression of cytotoxic myocardial injury." | 3.73 | MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats. ( Hattori, M; Kishimoto, C; Nimata, M; Okabe, TA; Shioji, K; Yuan, Z, 2005) |
| "Edaravone-treated DCM rats showed better cardiac function compared with those of the vehicle-treated rats." | 1.38 | Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy. ( Arozal, W; Arumugam, S; Giridharan, VV; Harima, M; Kodama, M; Nagata, M; Nakamura, T; Palaniyandi, SS; Sari, FR; Soetikno, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimazaki, H | 1 |
| Watanabe, K | 3 |
| Veeraveedu, PT | 3 |
| Harima, M | 3 |
| Thandavarayan, RA | 3 |
| Arozal, W | 2 |
| Tachikawa, H | 1 |
| Kodama, M | 3 |
| Aizawa, Y | 1 |
| Arumugam, S | 2 |
| Nakamura, T | 1 |
| Sari, FR | 1 |
| Giridharan, VV | 2 |
| Soetikno, V | 2 |
| Palaniyandi, SS | 1 |
| Suzuki, K | 2 |
| Nagata, M | 2 |
| Tagaki, R | 1 |
| Nimata, M | 1 |
| Okabe, TA | 1 |
| Hattori, M | 1 |
| Yuan, Z | 1 |
| Shioji, K | 1 |
| Kishimoto, C | 1 |
4 other studies available for edaravone and Myocarditis
| Article | Year |
|---|---|
The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis.
Topics: Animals; Antioxidants; Antipyrine; Apoptosis; Autoimmune Diseases; Disease Models, Animal; Down-Regu | 2010 |
Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antipyrine; Apoptosis; Autoimmune Di | 2012 |
Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Antipyrine; Autoimmune Diseases; Disease Models, Anim | 2012 |
MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats.
Topics: Acute Disease; Animals; Antipyrine; Autoimmune Diseases; Cardiotonic Agents; Cytokines; Dose-Respons | 2005 |